Several days ago, the “2019-nCoV nucleic acid detection reagent kit research, development and industrialization” project declared by Toneker Biotech in our city got support from Provincial Department of Science and Technology and Provincial Health Commission. As the only enterprise that meets conditions in the province, it is recommended by provincial medical products administration to National Medical Products Administration to access immediate channel of examination and approval.
To strengthen the application of existing scientific and technological achievements to provincial 2019-nCoV prevention forefront, a batch of detection technologies, prevention technologies, instruments and equipment, detection reagents and medicines for preventing and controlling 2019-nCoV are selected in our province. The transformation and application of scientific and technological achievements is accelerated. 10 projects in two batches of scientific research have been launched in our province to urgently control the epidemic. The main units of undertaking the projects are colleges, universities and other scientific research institutions. Toneker Biotech is the only private enterprise.
As the first high-level personnel team in our city, Toneker Biotech has its own patented products “human papilloma virus (15 types) nucleic acid detection kit (PCR multicolor fluorescence method)” and “TK-6000 real-time fluorescence instrument of quantitative PCR” which fill in the blank of diagnostic reagent, instrument and equipment for three kinds of molecule in Anhui Province. In addition, that plays positive leading function for scientific and technological innovation and development in our city. At present, the 2019-nCoV nucleic acid detection reagent kit developed by the company has been supplied to disease control centers. At the same time, it has donated many TK-6000 real-time fluorescence instruments of quantitative PCR and 5000 person-kits of 2019-nCoV nucleic acid detection reagent to Hubei Province and some other places.